MASSDEVICE ON CALL — Double mastectomy rates have doubled over the last 10 years, including some women who’ve opted to remove a healthy breast after discovering early-stage breast cancer in the other, but the extreme measure may not be doing them much good.
Breast Cancer
Breast cancer: Hologic touts ‘excellent’ results from 7-year MammoSite registry
SEC sues Imaging Diagnostic Systems and top execs amid failed FDA bids and IRS issues
American Cancer Society CMO: Money-driven hospitals push for dangerous tests
Routine screening has been touted as the most effective way to stem cancer deaths, but it may instead put patients in harm’s way, according to American Cancer Society chief medical officer Dr. Otis Brawley. Speaking at a seminar last week, Brawley warned that hospitals recommending regular screening may be looking out for their profits rather than their patients.
Docs call for breast cancer screening in all women over 40
Nothing beats early detection in preventing deaths related to breast cancer, a coalition of patient advocacy groups said, calling for routine mammography in all women aged 40 and older.
Delphinus Medical lands $6M from General Electric
General Electric (NYSE:GE) said its GE Capital arm lent $6 million to Delphinus Medical Technologies for its SoftVue whole breast tomography system.
The loan is aimed at "clinical and early commercialization efforts" for Plymouth, Mich.-based Delphinus, according to a press release.
Breast implants: Sientra touts legal win against Johnson & Johnson
Women’s health startup solicits crowd-funding for at-home breast exam device
California medical device startup Eclipse Breast Health Technologies is hoping the flurry of interest in crowd-funding will help it raise a hoped-for $650,000 through internet funding site IndieGoGo.
Eclipse has a ways to go, with just $868 raised so far in 2 days of solicitation, with 44 days before the end of the term.
Hologic takes SenoRx assets in out-of-court settlement with C.R. Bard
GE submits PMA for extended labeling for Senographe mammography
GE Healthcare (NYSE:GE) is hoping to extend FDA premarket approval for its Senographe Essential system to adds on 3D breast imaging, or tomosynthesis, to the device’s approved indications.
GE wins CE Mark for low-radiation 3D breast imaging
Life science titan GE Healthcare (NYSE:GE) landed a win in Europe for its SenoClaire 3D breast imaging system, which the company says exposes women to less radiation during breast cancer screening.